Many discharged COVID-19 patients affected by sequelae experience reduced quality of life
leading to an increased burden on the healthcare system, their families and society at large …

Abstract Coronavirus disease 2019 (COVID-19) caused by a novel coronavirus, severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in considerable …

Emerging evidence suggests that endothelial activation plays a central role in the
pathogenesis of acute respiratory distress syndrome (ARDS) and multiorgan failure in …

Severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2) is a worldwide health
concern, and new treatment strategies are needed. Targeting inflammatory innate immunity …

The coronavirus disease 2019 (COVID-19) pandemic continues to burden healthcare
systems worldwide. COVID-19 symptoms are highly heterogeneous, and the patient may be …

The global COVID-19 pandemic has become the largest public health challenge of recent
years. The incidence of COVID-19-related acute hypoxemic respiratory failure (AHRF) …

Background. Emerging evidences suggest that in severe COVID-19, multi-organ failure is
associated with a hyperinflammatory state (the so-called “cytokine storm”) in combination …

In a multicenter European retrospective study including 162 patients with COVID-19
occurring in essential thrombocythemia (ET, n= 48), polycythemia vera (PV, n= 42) …

Infection with the novel severe acute respiratory coronavirus-2 (SARS-CoV2) results in
COVID-19, a disease primarily affecting the respiratory system to provoke a spectrum of …

BACKGROUND It is common for severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection to occur in the gastrointestinal tract, which can present itself as an initial …